C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
12/2006
12/27/2006	CN1886372A 1-alkyl-3-thio-substituted indole-2-alkynoic acids useful for the treatment for alzheimer's disease and related conditions
12/27/2006	CN1291979C Imidazole compounds and their use as adenosine deaminase inhibitors
12/27/2006	CN1291975C New mandelic acid derivatives and their use as thrombase inhibitors
12/26/2006	US7153977 Ligands and methods for preparing same
12/26/2006	US7153973 Light, heat and oxidation resistance; stabilizers
12/26/2006	US7153972 Benzimidazole derivatives, their production and use
12/26/2006	US7153968 For therapy of asthma, chronic bronchitis, chronic obstructive pulmonary disease, eosinophilic granuloma, psoriasis and other benign or malignant proliferative skin diseases, endotoxic shock, laminitis in horses, colic in horses, septic shock, ulcerative colitis, Crohn's disease, reperfusion injury
12/26/2006	US7153960 Synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
12/26/2006	US7153959 treatment of tumor necrosis factor mediated disorders; asthma; inflammatory bowel disease; arthritis
12/26/2006	US7153958 Farnesyl transferase inhibiting benzoheterocyclic derivatives
12/26/2006	US7153889 Alzheimer's disease; antihistamines; attention deficit disorders; hyperactivity; bipolar disorders; cognition activators; psychological disorders; anticancer agents; antidepressants; antiepileptic agents; gastrointestinal disorders ; analgesics
12/26/2006	US7153883 Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
12/26/2006	US7153878 Substituted thiazoles and oxazoles, e.g., 4-{1-[4-[2-(2-Chloro-6-fluoro-phenyl)-ethyl]-2-(4-trifluoromethyl-phenyl)-thiazol-5-yl]-ethylsulfanyl}-2-methyl-phenoxy)-acetic acid; treating atherosclerosis and diabetes and creating Syndrome X
12/26/2006	US7153862 αv integrin receptor antagonists
12/26/2006	US7153860 5-Phenylpyrimidines, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi
12/26/2006	US7153858 antiserotonine agents; central nervous system disorders; anxiolytic agents; attention deficit disorders; strokes; headaches
12/26/2006	US7153853 Heterocyclic compounds and antitumor drugs containing the same as the active ingredient
12/21/2006	WO2006135828A2 Trisubstituted amines as phosphodiesterase 4 inhibitors
12/21/2006	WO2006135826A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/21/2006	WO2006135719A1 Aminopyrimidines as kinase modulators
12/21/2006	WO2006135644A1 Aminopyrimidines as kinase modulators
12/21/2006	WO2006135312A1 Trombin inhibiting 2,4-dioxo-3,4-dihydropyrimidine derivatives
12/21/2006	WO2006134613A2 Novel 5-substituted indole derivatives as dipeptidyl peptidase iv (dpp-iv) inhibitors
12/21/2006	WO2006134468A1 Substituted arylpyrazoles for use against parasitites
12/21/2006	WO2006134466A1 Substituted arylpyrazoles as parasiticidal agents
12/21/2006	WO2006134378A1 Compounds for the treatment of multi-drug resistant bacterial infections
12/21/2006	WO2006134318A1 Pyrazole-substituted benzimidazole derivatives for use in the treatment of cancer and autoimmune disorders
12/21/2006	WO2006134078A1 Method for obtaining benzimidazole derivatives and intermediates thereof
12/21/2006	WO2006134051A1 Cationic oligomeric azo dyes
12/21/2006	WO2006133946A1 Azab i cyclo [3 . 1 . 0] hexane derivatives as dopamin d3 receptor modulators
12/21/2006	WO2006133945A1 Novel compounds
12/21/2006	WO2006133926A1 Pyrazole derivates as cannabinoid receptor modulators
12/21/2006	WO2006133634A1 Tetrahydroindole derivatives and tetrahydroindazole derivatives, and use thereof
12/21/2006	WO2006133567A1 Helix 12 directed non-steroidal antiandrogens
12/21/2006	WO2006096709A3 Process for preparing amorphous salts
12/21/2006	WO2006092599A3 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
12/21/2006	WO2006087544A3 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
12/21/2006	WO2005118538A3 Arylsulfonamides and uses as hydroxysteroid dehydrogenase
12/21/2006	WO2005092856A8 Tetrahydrocarbazoles and derivatives
12/21/2006	US20060287537 Method of removing the triphenylmethane protecting group
12/21/2006	US20060287531 antiviral for HIV and AIDS; N-(1-Benzoyl-pyrrolidin-3-ylmethyl)-2-(4-fluoro-1H-indol-3-yl)-2-oxo-acetamide; N-(1-Benzoyl-pyrrolidin-3-ylmethyl)-2-oxo-2-(1H-pyrrolo[2,3-b]pyridin-3-yl)-acetamide
12/21/2006	US20060287381 Enhanced indolinone based protein kinase inhibitors
12/21/2006	US20060287380 To treat diseases of respiratory, urinary and gastrointestinal systems; highly selective; significant potency; (2R,2S)(1 alpha ,5 alpha ,6 alpha )-N-{-[4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyl]-3-azabicyclo[3.1.0]hex-6-yl-methyl}-2-hydroxy-2-cyclopentyl-2-phenylacetamide
12/21/2006	US20060287379 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer
12/21/2006	US20060287378 Novel pyrroles and imidazoles
12/21/2006	US20060287377 Vanilloid receptor 1 (VR 1) antagonists; efficacy; N-(3-Fluoro-4-methoxy-phenyl)-2-(7-nitro-1H-benzimidazol-1-yl)-acetamide,
12/21/2006	US20060287370 Isoindolinone kinase inhibitors
12/21/2006	US20060287369 Diarylmethyl and related compounds
12/21/2006	US20060287365 1-aryl-4-cyclopropylpyrazoles with at least one fluorine attached to the cyclopropyl ring; parasiticides; fleas; Extended duration of action for at least 28 days
12/21/2006	US20060287363 Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht 1f agonists
12/21/2006	US20060287340 e.g. 5-(4-fluorophenyl)-N-[2-(1-methyl-2-oxo-1,7-diazaspiro[4,4]nonan-7-yl)-6-quinolinyl]-2-pyrimidinecarboxamide; melanin concentrating hormone receptor antagonist; central nervous system disorders, cardiovascular disorders and metabolic disorders
12/21/2006	US20060287339 Aza- and polyazanthranyl amides and their use as medicaments
12/21/2006	US20060287334 e.g. 8-(4-(4-Fluorobenzyl)-piperazin-1-yl)-3-phenylsulfonylquinoline; serotonin receptor modulator; antidepressant, anxiolytic agent, cognition activator; schizophrenia, obesity, Alzheimer's disease
12/21/2006	US20060287330 Agonist or antgonist and binders and inversion of agonist; use in the treatment of metabolic, immune, infection-related and melanocortin receptor mediated disorders including specifically treatment of obesity and related conditions
12/21/2006	US20060287328 Fungicides; pest control; 1-Dimethyl-3-(2'-nitro)phenyl-silacyclohexene-2; Trans-1-(2'trifluoromethylsulfonyloxy-phenyl)-2-trimethylsilyl-cyclopropane
12/21/2006	US20060287326 17-Acetamido-4-azasteroid derivatives as androgen receptor modulators
12/21/2006	US20060287315 Pyrazinedicarboxamides and their use
12/21/2006	US20060287313 Isoquinoline compounds and methods of use thereof
12/21/2006	US20060287308 3-Aminoquinazolin-2,4-dione antibacterial agents
12/21/2006	US20060287306 Compounds to treat alzheimer's disease
12/21/2006	US20060287303 Modulators of muscarinic receptors
12/21/2006	US20060287302 Mitotic kinesin inhibitors
12/21/2006	US20060287298 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
12/21/2006	US20060287295 Antiproliferative agent in the prevention or treatment of tumors which are sensitive to inhibition of EGF and erbB receptor tyrosine kinases;1-({4-[(3-chloro-2-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}methyl)-L-prolinamide
12/21/2006	US20060287293 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction
12/21/2006	US20060287290 Azabicyclic compounds are central nervous system active agents
12/21/2006	US20060287252 Substances k01-0509 and process for producing the same
12/21/2006	US20060286673 Amino acid or peptide in sample with labels to form carbamate and isotopes
12/21/2006	DE19916460B4 Substituierte Benzimidazole, deren Herstellung und Anwendung Substituted benzimidazoles, their preparation and application
12/21/2006	CA2611562A1 Trisubstituted amines as phosphodiesterase 4 inhibitors
12/21/2006	CA2611495A1 Aminopyrimidines as kinase modulators
12/21/2006	CA2611470A1 Aminopyrimidines as kinase modulators
12/21/2006	CA2611378A1 Aminoquinoline and aminoquinazoline kinase modulators
12/21/2006	CA2610900A1 Compounds for the treatment of multi-drug resistant bacterial infections
12/21/2006	CA2610588A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/21/2006	CA2610429A1 Trombin inhibiting 2,4-dioxo-3,4-dihydropyrimidine derivatives
12/21/2006	CA2610411A1 Resolution of enantiomeric mixtures of .beta.-lactams
12/20/2006	EP1734040A1 Substituted quinazoline or pyridopyrimidine derivative
12/20/2006	EP1732922A1 Methods for minimizing thioamide impurities
12/20/2006	EP1732921A1 Thioamide derivatives as progesterone receptor modulators
12/20/2006	EP1732918A1 Novel pyrrolidine-3,4-dicarboxamide derivatives
12/20/2006	EP1732904A1 Diaryltriazoles as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
12/20/2006	EP1732901A1 Antiviral 4-aminocarbonylamino-substituted imidazole compound
12/20/2006	EP1732900A2 Acrylonitrile derivatives for inflammation and immune-related uses
12/20/2006	EP1732892A1 Tetrahydrocarbazoles and derivatives
12/20/2006	EP1732890A1 Crystalline polymorph of a bazedoxifene acetate
12/20/2006	EP1732884A1 Sulphonamide derivatives
12/20/2006	EP1732564A1 Biaryl substituted pyrazinones as sodium channel blockers
12/20/2006	EP1732560A1 Substituted cinnolin-4-ylamines
12/20/2006	EP1732385A1 Use of (3-(1-(3-phenyl-propenyl)-piperidin-4-yl)-2,3-dihydro-indol-1-yl)-(pyridin-4-yl)-methanone derivatives and related compounds as insecticides
12/20/2006	EP1542977B1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12.
12/20/2006	EP1509501B1 1-(aminoalkyl)-3-sulfonylindole and -indazole derivatives as 5-hydroxytryptamine-6 ligands
12/20/2006	EP1187816B1 5-cyano-2-aminopyrimidine derivatives
12/20/2006	CN1882857A Filter for electronic display
12/20/2006	CN1882588A A2B adenosine receptor antagonists
12/20/2006	CN1882578A 2,4 di (hetero) -arylamino-pyrimidine derivatives as zap-70 and/or syk inhibitors
12/20/2006	CN1882577A 喹唑啉衍生物 Quinazoline derivatives
12/20/2006	CN1882576A 喹唑啉衍生物 Quinazoline derivatives
12/20/2006	CN1882575A Substituted pyrrole-indoles as inhibitors of PAI-1
12/20/2006	CN1882574A Pyrazolyl and imidazolyl pyrimidines

1 ... 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 ... 626